静脉利多卡因在ERCP丙泊酚镇静中的疗效与安全性:前瞻性随机双盲对照试验
结果显示利多卡因组丙泊酚用量减少33.8%,不自主运动更少,术后疼痛和疲劳评分显著降低,氧饱和度下降、低血压和心动过缓发生率有降低趋势。
要点
- 静脉利多卡因可减少ERCP丙泊酚镇静中33.8%的丙泊酚用量。
- 利多卡因组不自主运动发生率更低(12.5% vs 41.7%)。
- 利多卡因组术后疼痛和疲劳视觉模拟评分显著降低。
核心结论
- 静脉利多卡因可显著减少ERCP期间丙泊酚用量,并提高镇静质量和内镜医师满意度。
主要发现
- 利多卡因组丙泊酚用量较对照组减少33.8%(212.0 ± 118.2 mg vs 320.0 ± 189.6 mg,P = .023)。
- 利多卡因组不自主运动发生率低于对照组(12.5% vs 41.7%,P = .049)。
- 利多卡因组术后疼痛视觉模拟评分显著降低(0 [范围,0-4] vs 3 [范围,0-5],P = .005)。
- 利多卡因组术后疲劳视觉模拟评分显著降低(2 [范围,0-4] vs 5 [范围,2-8],P < .001)。
- 氧饱和度下降、低血压和心动过缓发生率在利多卡因组有降低趋势。
关键数值与推荐
- 利多卡因组给予1.5 mg/kg静脉推注后以2 mg/kg/h持续输注,对照组给予等体积生理盐水。
临床怎么用
- ERCP丙泊酚镇静时可考虑辅助静脉利多卡因以减少丙泊酚用量并改善术后恢复体验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Propofol-based sedation is widely used in ERCP procedures, but adverse respiratory or cardiovascular events commonly occur. Intravenous injection of lidocaine has an analgesic effect and can reduce the requirements of fentanyl and propofol during abdominal surgery. The objective of this study was to assess the efficacy and safety of intravenous lidocaine on propofol requirements during ERCP procedures. METHODS: Forty-eight patients scheduled for ERCP were randomly divided into 2 groups, the lidocaine group and the control group. All patients received .02 mg/kg midazolam and .1 μg/kg sufentanil intravenously as premedication. A bolus of propofol was applied for induction of sedation, and perfusion of propofol was applied for maintenance. Patients in the lidocaine group received a bolus of 1.5 mg/kg lidocaine intravenously followed by continuous infusion of 2 mg/kg/h, whereas the control group received the same volumes of saline solution. The primary outcome was the propofol requirement during ERCP. RESULTS: Compared with the control group, propofol requirements were reduced by 33.8% in the lidocaine group (212.0 ± 118.2 mg vs 320.0 ± 189.6 mg, P = .023). Involuntary movement was less common in the lidocaine group than in the control group (12.5% vs 41.7%, P = .049). In the lidocaine group, postprocedure pain and fatigue, as measured by the visual analog scale, were significantly reduced (0 [range, 0-4] vs 3 [range, 0-5], P = .005; 2 [range, 0-4] vs 5 [range, 2-8], P < .001).The incidence of oxygen desaturation, hypotension, and bradycardia tended to be lower in the lidocaine group. CONCLUSIONS: Intravenous lidocaine can significantly decrease propofol requirements during ERCP, with higher sedation quality and endoscopist satisfaction. (Clinical trial registration number: NCT03996577.).
引用
- Liu J, Liu X, Peng LP, et al. Efficacy and safety of intravenous lidocaine in propofol-based sedation for ERCP procedures: a prospective, randomized, double-blinded, controlled trial. Gastrointest Endosc. 2020. PMID: 32156544. doi:10.1016/j.gie.2020.02.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。